Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Blanchet

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Journal of Pediatric Hematology/Oncology|August 1, 1996
Myelodysplastic syndrome with t(5;12)(q31;p12-p13) and eosinophilia: a pediatric case with review of literatureI Pellier, P J Le Moine, X Rialland, et al.
Genes, Chromosomes & Cancer|August 26, 1998
Deregulated expression of the TAL1 gene by t(1;5)(p32;31) in patient with T-cell acute lymphoblastic leukemiaS François, E Delabesse, L Baranger, et al.
Blood|November 14, 1997
Several cytogenetic subclones may be identified within plasma cells from patients with monoclonal gammopathy of undetermined significance, both at diagnosis and during the indolent course of this conditionM Zandecki, J L Laï, F Geneviève, et al.
Human Reproduction (Oxford, England)|February 12, 2022
Mitochondrial DNA content reduction in the most fertile spermatozoa is accompanied by increased mitochondrial DNA rearrangementM Boguenet, V Desquiret-Dumas, D Goudenège, et al.
Annales De Biologie Clinique|December 7, 2005
[Refractory anaemia with ringed sideroblasts (RARS) associated with marked thrombocytosis: a provisional entity in the WHO classification of haematological malignancies]J Gérard, F Dubois-Galopin, M Gardembas-Pain, et al.
Annales De Biologie Clinique|June 14, 2005
[Idiopathic hypereosinophilic syndrome: toward a new molecular-targeted therapy and a new cytomorphological and molecular definition]M-P Moles, J Landry, C Roche-Lestienne, et al.
Leukemia|October 23, 2009
Influence of NPM1 and FLT3-ITD status on outcome in relapsed/refractory AML patients receiving salvage therapy including gemtuzumab ozogamicinP Chevallier, T Prebet, A Pigneux, et al.
Bone Marrow Transplantation|May 16, 2003
A potential graft-versus-leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: results from the French Bone Marrow Transplantation SocietyH Espérou, J-M Boiron, J-M Cayuela, et al.
Leukemia|February 19, 2011
A new Leukemia Prognostic Scoring System for refractory/relapsed adult acute myelogeneous leukaemia patients: a GOELAMS studyP Chevallier, M Labopin, P Turlure, et al.
Alimentary Pharmacology & Therapeutics|March 27, 2018
Screening for therapeutic trials and treatment indication in clinical practice: MACK-3, a new blood test for the diagnosis of fibrotic NASHJ Boursier, R Anty, L Vonghia, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Journal of Pediatric Hematology/Oncology|August 1, 1996
Myelodysplastic syndrome with t(5;12)(q31;p12-p13) and eosinophilia: a pediatric case with review of literatureI Pellier, P J Le Moine, X Rialland, et al.
Genes, Chromosomes & Cancer|August 26, 1998
Deregulated expression of the TAL1 gene by t(1;5)(p32;31) in patient with T-cell acute lymphoblastic leukemiaS François, E Delabesse, L Baranger, et al.
Blood|November 14, 1997
Several cytogenetic subclones may be identified within plasma cells from patients with monoclonal gammopathy of undetermined significance, both at diagnosis and during the indolent course of this conditionM Zandecki, J L Laï, F Geneviève, et al.
Human Reproduction (Oxford, England)|February 12, 2022
Mitochondrial DNA content reduction in the most fertile spermatozoa is accompanied by increased mitochondrial DNA rearrangementM Boguenet, V Desquiret-Dumas, D Goudenège, et al.
Annales De Biologie Clinique|December 7, 2005
[Refractory anaemia with ringed sideroblasts (RARS) associated with marked thrombocytosis: a provisional entity in the WHO classification of haematological malignancies]J Gérard, F Dubois-Galopin, M Gardembas-Pain, et al.
Annales De Biologie Clinique|June 14, 2005
[Idiopathic hypereosinophilic syndrome: toward a new molecular-targeted therapy and a new cytomorphological and molecular definition]M-P Moles, J Landry, C Roche-Lestienne, et al.
Leukemia|October 23, 2009
Influence of NPM1 and FLT3-ITD status on outcome in relapsed/refractory AML patients receiving salvage therapy including gemtuzumab ozogamicinP Chevallier, T Prebet, A Pigneux, et al.
Bone Marrow Transplantation|May 16, 2003
A potential graft-versus-leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: results from the French Bone Marrow Transplantation SocietyH Espérou, J-M Boiron, J-M Cayuela, et al.
Leukemia|February 19, 2011
A new Leukemia Prognostic Scoring System for refractory/relapsed adult acute myelogeneous leukaemia patients: a GOELAMS studyP Chevallier, M Labopin, P Turlure, et al.
Alimentary Pharmacology & Therapeutics|March 27, 2018
Screening for therapeutic trials and treatment indication in clinical practice: MACK-3, a new blood test for the diagnosis of fibrotic NASHJ Boursier, R Anty, L Vonghia, et al.
Pageof 3